S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
MarketBeat Week in Review – 1/30 - 2/3
“Future Fuel” will unleash $11 trillion wave of wealth (Ad)
State of the Union: Biden sees economic glow, GOP sees gloom
Why a new Alzheimer's drug is having a slow US debut
A gold storm is coming… (Ad)
Sri Lanka marks independence anniversary amid economic woes
Tesla hikes price of Model Y after US alters tax credit rule
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Disney World unions vote down offer covering 45,000 workers
Route to Super Bowl dangerous for Mexico's avocado haulers
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
MarketBeat Week in Review – 1/30 - 2/3
“Future Fuel” will unleash $11 trillion wave of wealth (Ad)
State of the Union: Biden sees economic glow, GOP sees gloom
Why a new Alzheimer's drug is having a slow US debut
A gold storm is coming… (Ad)
Sri Lanka marks independence anniversary amid economic woes
Tesla hikes price of Model Y after US alters tax credit rule
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Disney World unions vote down offer covering 45,000 workers
Route to Super Bowl dangerous for Mexico's avocado haulers
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
MarketBeat Week in Review – 1/30 - 2/3
“Future Fuel” will unleash $11 trillion wave of wealth (Ad)
State of the Union: Biden sees economic glow, GOP sees gloom
Why a new Alzheimer's drug is having a slow US debut
A gold storm is coming… (Ad)
Sri Lanka marks independence anniversary amid economic woes
Tesla hikes price of Model Y after US alters tax credit rule
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Disney World unions vote down offer covering 45,000 workers
Route to Super Bowl dangerous for Mexico's avocado haulers
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
MarketBeat Week in Review – 1/30 - 2/3
“Future Fuel” will unleash $11 trillion wave of wealth (Ad)
State of the Union: Biden sees economic glow, GOP sees gloom
Why a new Alzheimer's drug is having a slow US debut
A gold storm is coming… (Ad)
Sri Lanka marks independence anniversary amid economic woes
Tesla hikes price of Model Y after US alters tax credit rule
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Disney World unions vote down offer covering 45,000 workers
Route to Super Bowl dangerous for Mexico's avocado haulers
NASDAQ:MASI

Masimo - MASI Stock Forecast, Price & News

$169.45
-5.27 (-3.02%)
(As of 02/3/2023 12:00 AM ET)
Add
Compare
Today's Range
$168.49
$173.60
50-Day Range
$138.49
$174.72
52-Week Range
$108.89
$237.85
Volume
402,161 shs
Average Volume
422,674 shs
Market Capitalization
$8.91 billion
P/E Ratio
56.11
Dividend Yield
N/A
Price Target
$188.00

Masimo MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.88 Rating Score
Upside/​Downside
10.9% Upside
$188.00 Price Target
Short Interest
Healthy
2.99% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.86
Upright™ Environmental Score
News Sentiment
0.24mentions of Masimo in the last 14 days
Based on 6 Articles This Week
Insider Trading
Acquiring Shares
$5.99 M Bought Last Quarter
Proj. Earnings Growth
-1.80%
From $4.44 to $4.36 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.47 out of 5 stars

Medical Sector

145th out of 1,028 stocks

Electromedical Equipment Industry

2nd out of 24 stocks

MASI stock logo

About Masimo (NASDAQ:MASI) Stock

Masimo Corp. is a medical technology company, which develops, manufactures and markets noninvasive patient monitoring technologies, medical devices and sensors. Its products include continuous monitors, patient-worn monitors, hospital automation connectivity, capnography & gas, data download & analytics and sensors & accessories. The company was founded by Joe E. Kiani in May 1989 and is headquartered in Irvine, CA.

Receive MASI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Masimo and its competitors with MarketBeat's FREE daily newsletter.

MASI Stock News Headlines

A gold storm is coming…
“We are in the early stages of a mania – the calm before the storm.”...
Should You Hold Masimo Corporation (MASI)?
“Future Fuel” will unleash $11 trillion wave of wealth
The next major energy revolution is unfolding right now. And it could hand early investors as much as 46,700% gains…
Masimo Announces Limited Market Release of Sepsis Index
H2O: the FT investigation’s big finale
See More Headlines
Receive MASI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Masimo and its competitors with MarketBeat's FREE daily newsletter.

MASI Company Calendar

Last Earnings
11/08/2022
Today
2/04/2023
Next Earnings (Estimated)
2/21/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Electromedical equipment
Sub-Industry
Health Care Equipment
Sector
Medical
Current Symbol
NASDAQ:MASI
CUSIP
57479510
Employees
6,200
Year Founded
1989

Price Target and Rating

Average Stock Price Forecast
$188.00
High Stock Price Forecast
$295.00
Low Stock Price Forecast
$135.00
Forecasted Upside/Downside
+10.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.88
Research Coverage
8 Analysts

Profitability

Net Income
$229.65 million
Pretax Margin
12.28%

Debt

Sales & Book Value

Annual Sales
$1.24 billion
Cash Flow
$4.66 per share
Book Value
$28.00 per share

Miscellaneous

Free Float
47,466,000
Market Cap
$8.91 billion
Optionable
Optionable
Beta
0.87

Social Links


Key Executives

  • Joe E. KianiJoe E. Kiani
    Chairman & Chief Executive Officer
  • Bilal MuhsinBilal Muhsin
    Chief Operating Officer
  • Micah YoungMicah Young
    Chief Financial Officer & Executive Vice President
  • Yongsam Lee
    Chief Information Officer & Executive VP
  • Anand SampathAnand Sampath
    Executive VP-Operations & Clinical Research













MASI Stock - Frequently Asked Questions

Should I buy or sell Masimo stock right now?

8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Masimo in the last twelve months. There are currently 1 hold rating and 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" MASI shares.
View MASI analyst ratings
or view top-rated stocks.

What is Masimo's stock price forecast for 2023?

8 analysts have issued 12 month price objectives for Masimo's shares. Their MASI share price forecasts range from $135.00 to $295.00. On average, they predict the company's stock price to reach $188.00 in the next year. This suggests a possible upside of 10.9% from the stock's current price.
View analysts price targets for MASI
or view top-rated stocks among Wall Street analysts.

How have MASI shares performed in 2023?

Masimo's stock was trading at $147.95 on January 1st, 2023. Since then, MASI shares have increased by 14.5% and is now trading at $169.45.
View the best growth stocks for 2023 here
.

When is Masimo's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 21st 2023.
View our MASI earnings forecast
.

How were Masimo's earnings last quarter?

Masimo Co. (NASDAQ:MASI) announced its earnings results on Tuesday, November, 8th. The medical equipment provider reported $1.00 EPS for the quarter, beating analysts' consensus estimates of $0.92 by $0.08. The medical equipment provider had revenue of $549.30 million for the quarter, compared to analyst estimates of $533.96 million. Masimo had a trailing twelve-month return on equity of 18.04% and a net margin of 9.78%.

What guidance has Masimo issued on next quarter's earnings?

Masimo updated its FY 2023 earnings guidance on Wednesday, December, 14th. The company provided earnings per share (EPS) guidance of $4.25-$4.45 for the period, compared to the consensus estimate of $4.43. The company issued revenue guidance of $2.33 billion-$2.40 billion, compared to the consensus revenue estimate of $2.36 billion.

What is Joe E. Kiani's approval rating as Masimo's CEO?

136 employees have rated Masimo Chief Executive Officer Joe E. Kiani on Glassdoor.com. Joe E. Kiani has an approval rating of 90% among the company's employees.

What other stocks do shareholders of Masimo own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Masimo investors own include NVIDIA (NVDA), Netflix (NFLX), Shopify (SHOP), Okta (OKTA), PayPal (PYPL), Alibaba Group (BABA), Mastercard (MA), Trade Desk (TTD), Walt Disney (DIS) and Twilio (TWLO).

What is Masimo's stock symbol?

Masimo trades on the NASDAQ under the ticker symbol "MASI."

Who are Masimo's major shareholders?

Masimo's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Sumitomo Mitsui Trust Holdings Inc. (0.73%), Bank of Montreal Can (0.39%), Baillie Gifford & Co. (0.18%), New York State Common Retirement Fund (0.13%), New York State Teachers Retirement System (0.12%) and DekaBank Deutsche Girozentrale (0.10%). Insiders that own company stock include Adam Mikkelson, Anand Sampath, Bilal Muhsin, Craig B Reynolds, H Michael Cohen, Joe E Kiani, Jon Coleman, Micah W Young, Ramshorst David J Van, Tao Levy, Thomas Samuel Mcclenahan and Yongsam Lee.
View institutional ownership trends
.

How do I buy shares of Masimo?

Shares of MASI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Masimo's stock price today?

One share of MASI stock can currently be purchased for approximately $169.45.

How much money does Masimo make?

Masimo (NASDAQ:MASI) has a market capitalization of $8.91 billion and generates $1.24 billion in revenue each year. The medical equipment provider earns $229.65 million in net income (profit) each year or $3.02 on an earnings per share basis.

How many employees does Masimo have?

The company employs 6,200 workers across the globe.

How can I contact Masimo?

Masimo's mailing address is 52 DISCOVERY, IRVINE CA, 92618. The official website for the company is www.masimo.com. The medical equipment provider can be reached via phone at (949) 297-7000, via email at ekammerman@masimo.com, or via fax at 949-297-7001.

This page (NASDAQ:MASI) was last updated on 2/5/2023 by MarketBeat.com Staff